Sanofi/GSK Arixtra Adds DVT, Pulmonary Embolism Treatment Indications
Expanded indication comes as Sanofi prepares to divest Arixtra to GlaxoSmithKline in connection with its proposed acquisition of Lovenox-maker Aventis.
Expanded indication comes as Sanofi prepares to divest Arixtra to GlaxoSmithKline in connection with its proposed acquisition of Lovenox-maker Aventis.